Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 24, 2018

DrugPatentWatch Database Preview

Teva Parenteral Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?

TEVA PARENTERAL has forty-seven approved drugs.

There are six tentative approvals on TEVA PARENTERAL drugs.

Summary for Teva Parenteral

US Patents:	0
Tradenames:	39
Ingredients:	37
NDAs:	47
Patent Litigation for Teva Parenteral:	See patent lawsuits for Teva Parenteral

Drugs and US Patents for Teva Parenteral

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Parenteral	AMPHOTERICIN B	amphotericin b	INJECTABLE;INJECTION	064062-001	Mar 31, 1995		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Teva Parenteral	BLEOMYCIN SULFATE	bleomycin sulfate	INJECTABLE;INJECTION	064084-001	Jun 1, 1996		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Teva Parenteral	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	072999-001	Oct 23, 1991		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-003	Dec 21, 1987		DISCN	Yes	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Teva Parenteral

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-001	Approved Prior to Jan 1, 1982	3,444,294	➤ Try a Free Trial
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-002	Approved Prior to Jan 1, 1982	3,444,294	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture

Citi

Federal Trade Commission

Moodys

Johnson and Johnson

US Department of Justice

Teva

AstraZeneca

Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.